◆英語タイトル：Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review
Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. Its technology platforms include Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs) and Hematopoietic Stem Cells (HSCs). Mesoblast serves various therapeutic areas such as immunologic/ inflammatory, cardiac vascular, spine disease, ophthalmolog, neurologic and oncology. The company has partnership with Teva Pharmaceutical Industries Ltd., JCR Pharmaceuticals Co. Ltd. and Lonza Group. It has operational presence in the US and Singapore. Mesoblast is headquartered in Melbourne, Victoria, Australia.
Mesoblast Limited Key Recent Developments
Nov 25, 2013: New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products
Aug 29, 2013: Mesoblast’s Strong Cash Position Enables Execution of Late-Stage Clinical Trials
Jul 18, 2013: Mesoblast Receives $4.3 Million from Australian Government for Adult Stem Cell Pipeline Development
Jun 05, 2013: Mesoblast Obtains Key Japanese Patent Covering Mesenchymal Precursor Cells
Feb 13, 2013: Mesoblast Announces FDA Agreement On Its Use Of Singapore Manufacturing Facility For Clinical Trial Production Of Mesenchymal Precursor Cells
This comprehensive SWOT profile of Mesoblast Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mesoblast Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Mesoblast Limited – Key Information
Mesoblast Limited – Overview
Mesoblast Limited – Key Employees
Mesoblast Limited – Key Employee Biographies
Mesoblast Limited – Key Operational Heads
Mesoblast Limited – Major Products and Services
Mesoblast Limited – History
Mesoblast Limited – Company Statement
Mesoblast Limited – Locations And Subsidiaries
Mesoblast Limited – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Mesoblast Limited – Business Description
Mesoblast Limited – Corporate Strategy
Mesoblast Limited – SWOT Analysis
SWOT Analysis – Overview
Mesoblast Limited – Strengths
Mesoblast Limited – Weaknesses
Mesoblast Limited – Opportunities
Mesoblast Limited – Threats
Mesoblast Limited – Key Competitors
Section 3 – Company Financial Performance Charts
Mesoblast Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Mesoblast Limited, Key Information
Mesoblast Limited, Key Ratios
Mesoblast Limited, Share Data
Mesoblast Limited, Major Products and Services
Mesoblast Limited, History
Mesoblast Limited, Key Employees
Mesoblast Limited, Key Employee Biographies
Mesoblast Limited, Key Operational Heads
Mesoblast Limited, Other Locations
Mesoblast Limited, Subsidiaries
Mesoblast Limited, Key Manufacturing facilities
Mesoblast Limited, Key Competitors
Mesoblast Limited, SWOT Analysis
Mesoblast Limited, Ratios based on current share price
Mesoblast Limited, Annual Ratios
Mesoblast Limited, Interim Ratios
Capital Market Ratios
List of Figures
Mesoblast Limited, Performance Chart
Mesoblast Limited, Ratio Charts
| ★海外企業調査レポート[Mesoblast Limited (MSB)：企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら